Author

J. Dehedin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Arabo· 1 shared A. B. Cortot· 1 shared A. Bardelli· 1 shared A. Guernet· 1 shared A. Vinchent· 1 shared B. C. Cho· 1 shared C. Berard· 1 shared C. Cheng· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Arabo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells

L. Brunet, D. Alexandre, J. Lee, M. d. M. Blanquer-Rossello, A. Guernet, H. Chhouri, Z. Kherrouche, A. Arabo, S. Yao, D. Godefroy, J. Dehedin, J.-R. Li, C. Duparc, P. Jamme, A. Vinchent, , L. Grumolato

This study shows that sorafenib can prolong lung cancer response to EGFR inhibitors by targeting resistant cells' selective advantage.

bioRxiv · Jun 19, 2023Cancer Biology